USFDA staff flags concerns about Merck chronic cough drug Ruchika Sharma16 Nov 2023 1:25 PM ISTStaff assessment of the data submitted by Merck showed a small reduction in cough frequency and side effects such as loss of taste in patients who...
Merck gets positive EMA Committee opinion for Keytruda plus Gemcitabine, Cisplatin for Biliary Tract Cancer Ruchika Sharma14 Nov 2023 2:00 PM ISTRahway: Merck, known as MSD outside of the United States and Canada, has announced the European Medicines Agency's Committee for Medicinal...
Merck, Huma Therapeutics collaborate to develop digital solution for cancer patients Ruchika Sharma12 Nov 2023 11:00 AM ISTLondon: Huma Therapeutics, a global digital health company, and Merck KGaA, Darmstadt, Germany, a science and technology company, have announced...
Merck bags USFDA nod for Keytruda plus gemcitabine, cisplatin to treat Biliary Tract Cancer Ruchika Sharma2 Nov 2023 2:30 PM ISTKEYTRUDA is an anti-programmed death receptor-1 (PD-1) therapy that works by increasing the ability of the body's immune system to help detect and...
Merck strengthens oncology pipeline through strategic partnership with Hengrui Ruchika Sharma31 Oct 2023 2:28 PM ISTGermany: Merck, a science and technology company, has announced a strategic collaboration with Jiangsu Hengrui Pharmaceuticals Co. Ltd. The...
Merck discontinues some cancer drug development with Sichuan Kelun Pharma Ruchika Sharma26 Oct 2023 2:38 PM ISTShanghai: Chinese drugmaker Sichuan Kelun Pharmaceutical Co has said that Merck & Co Inc was abandoning the joint development of...
Merck-Daiichi Sankyo ink pact for patritumab deruxtecan,ifinatamab deruxtecan, raludotatug deruxtecan Ruchika Sharma22 Oct 2023 1:45 PM ISTDesigned using Daiichi Sankyo's proprietary DXd ADC technology to target and deliver a cytotoxic payload inside cancer cells that express a specific...
European Commission nod to Merck Keytruda for non-small cell lung cancer at high risk of recurrence Ruchika Sharma17 Oct 2023 3:30 PM ISTRahway: Merck, known as MSD outside of the United States and Canada, has announced that the European Commission (EC) has approved KEYTRUDA,...
Merck gets USFDA nod for neoadjuvant/ adjuvant Keytruda for resectable non-small cell lung cancer Ruchika Sharma17 Oct 2023 12:54 PM ISTThe approval marks the sixth NSCLC indication for KEYTRUDA.
Merck Keytruda met primary endpoint of disease free survival in certain patients with Muscle-Invasive Urothelial Carcinoma after surgery Ruchika Sharma10 Oct 2023 11:30 AM ISTKEYTRUDA is an anti-programmed death receptor-1 (PD-1) therapy that works by increasing the ability of the body's immune system to help detect and...
Merck Sotatercept for pulmonary arterial hypertension gets USFDA priority review Ruchika Sharma30 Sept 2023 11:00 AM ISTRahway: Merck, known as MSD outside of the United States and Canada, has announced that the U.S. Food and Drug Administration (FDA) has accepted for...
Merck Keytruda plus Padcev improves survival in advanced or metastatic urothelial carcinoma Ruchika Sharma24 Sept 2023 3:30 PM ISTRahway: Merck, known as MSD outside of the United States and Canada, has announced positive topline results from the Phase 3 KEYNOTE-A39...
